Global Search

Search articles, concepts, and chapters

J GlaucomaNovember 20215 citations

Effect of Prostaglandin Analogues on Corneal Biomechanical Parameters Measured With a Dynamic Scheimpflug Analyzer.

Yasukura Yuichi, Miki Atsuya, Maeda Naoyuki, Koh Shizuka, Nishida Kohji


AI Summary

Topical PGAs for glaucoma increase corneal compliance, potentially leading to overestimation of their IOP-lowering effect due to altered corneal measurements.

Abstract

Prcis: Treatment with topical prostaglandin analogues (PGAs) induces increased corneal compliance in glaucoma eyes measured with a dynamic Scheimpflug analyzer.

Purpose

The purpose of this study was to evaluate the effect of topical PGAs on the corneal biomechanical properties.

Methods

We retrospectively studied the biomechanical parameters of 31 eyes of 19 consecutive patients with glaucoma measured using a dynamic Scheimpflug analyzer (Corvis ST) before and after initiation of treatment with topical PGAs. No patients had a history of glaucoma treatment before the study and no other antiglaucoma medication was used during the study period. Nine biomechanical parameters were evaluated before and 61.6±28.5 days (range: 21 to 105 d) after initiation of the treatment. The changes in the corneal biomechanical parameters before and after treatment were analyzed using multivariable models adjusting for intraocular pressure and central corneal thickness. The Benjamini-Hochberg method was used to correct for multiple comparison.

Results

In multivariable models, PGA treatment resulted in shorter inward applanation time (P=0.016, coefficient=-0.151) and larger deflection amplitude (P=0.023, coefficient=0.055), peak distance (P=0.042, coefficient=0.131), and deformation amplitude ratio at 1 mm (P=0.018, coefficient=0.028). These associations consistently indicated increased corneal compliance (deformability) after PGA treatment.

Conclusion

Topical PGAs resulted in greater corneal compliance, suggesting that the changes in the corneal biomechanical properties may lead to overestimation of the intraocular pressure-lowering effects.


MeSH Terms

Biomechanical PhenomenaCorneaGlaucoma, Open-AngleHumansIntraocular PressureProstaglandins, SyntheticRetrospective StudiesTonometry, Ocular

Key Concepts6

Treatment with topical prostaglandin analogues (PGAs) induces increased corneal compliance in glaucoma eyes, measured with a dynamic Scheimpflug analyzer.

MechanismCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

In multivariable models, topical prostaglandin analogue (PGA) treatment in glaucoma patients resulted in a shorter inward applanation time (P=0.016, coefficient=-0.151) as measured by a dynamic Scheimpflug analyzer.

MechanismCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

In multivariable models, topical prostaglandin analogue (PGA) treatment in glaucoma patients resulted in a larger deflection amplitude (P=0.023, coefficient=0.055) as measured by a dynamic Scheimpflug analyzer.

MechanismCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

In multivariable models, topical prostaglandin analogue (PGA) treatment in glaucoma patients resulted in a larger peak distance (P=0.042, coefficient=0.131) as measured by a dynamic Scheimpflug analyzer.

MechanismCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

In multivariable models, topical prostaglandin analogue (PGA) treatment in glaucoma patients resulted in a larger deformation amplitude ratio at 1 mm (P=0.018, coefficient=0.028) as measured by a dynamic Scheimpflug analyzer.

MechanismCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

The changes in corneal biomechanical properties induced by topical prostaglandin analogues (PGAs) may lead to an overestimation of the intraocular pressure-lowering effects in glaucoma patients.

PrognosisCohortRetrospective Cohort Studyn=31 eyes of 19 patientsCh3Ch31

Is this article assigned to the wrong chapter(s)? Let us know.